Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

News > All

Total search results: 12001 | Ordered by Date (descending)
1 2 3 ... 119 120 121  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Immatics Biotechnologies GmbH. (2/20/20). "Press Release: Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies". Tübingen & Houston, TX. 2020-02-20
France Biotech. (2/19/20). "Press Release: Driven by Its Successful Debut, the Second Annual International HealthTech Innovation Days Will Take Place in Paris on June 22nd & 23rd". Paris. 2020-02-19
Cellectis S.A.. (2/18/20). "Press Release: Cellectis and Servier Expand Collaboration on UCART19 Products". New York, NY. 2020-02-18
Univercells S.A.. (2/18/20). "Press Release: Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies". Brussels. 2020-02-18
Novartis AG. (2/17/20). "Press Release: Novartis Receives EC Approval for Beovu, a Next-generation anti-VEGF Treatment for wet AMD, a Leading Cause of Blindness Worldwide". Basel. 2020-02-17
TrakCel Ltd.. (2/17/20). "Press Release: TrakCel Appoints Dr Fiona Withey as Chief Executive Officer". Cardiff. 2020-02-17
PharmaMar S.A.. (2/17/20). "Press Release: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer". Madrid & Dublin. 2020-02-17
Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. 2020-02-17
Rentschler Biopharma SE. (2/13/20). "Press Release: Rentschler Biopharma Adds Senior Executive to Growing U.S. Team. Grace Kim Joins as Vice President Business Development – North America and APAC". Laupheim & Milford, MA. 2020-02-13
Sophia Genetics S.A.. (2/13/20). "Press Release: Sophia Genetics Appoints Chief Medical Officer to Accelerate the Execution of Medical Strategy. Dr. Philippe Menu Joins Sophia Genetics". Lausanne & Boston, MA. 2020-02-13
ProteoMedix AG. (2/11/20). "Press Release: New Data from Proclarix together with Magnetic Resonance Imaging (MRI) for Improved Prostate Cancer Diagnosis to Be Showcased at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium". Zür 2020-02-11
Stilla Technologies S.A.S.. (2/11/20). "Press Release: Stilla Technologies Raises €20 Million ($22 Million) in Series B Round that Brings in New Investor, TUS-Holdings, alongside Existing Ones". Paris. 2020-02-11
Roche. (2/10/20). "Press Release: Roche Provides Topline Results from Investigator-led Phase II/III Trial with Gantenerumab in Rare Inherited Form of Alzheimer’s Disease". Basel. 2020-02-10
ERS Genomics Ltd.. (2/10/20). "Press Release: ERS Genomics Provides Comment on Affirmation of Key CRISPR-Cas9 Patent Involved in European Opposition Proceedings". Dublin. 2020-02-10
Orphazyme A/S. (2/7/20). "Press Release: Orphazyme Completes Offering of 7,032,937 Shares in a Directed Issue and Private Placement and Raises approximately DKK 745,000,000 (EUR 100 Million / USD 110 Million) [Not for US, CA, JP or AU]". Copenhagen. 2020-02-07
Roche. (2/6/20). "Press Release: Roche’s Risdiplam Showed Significant Improvement in Motor Function in People Aged 2-25 with Type 2 or 3 Spinal Muscular Atrophy". Basel. 2020-02-06
Agilent Technologies Inc.. (2/6/20). "Press Release: Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation". Santa Clara, CA. 2020-02-06
Lunaphore Technologies S.A.. (2/6/20). "Press Release: Lunaphore Receives CHF 23M Series C Financing, Led by PHC Holdings Corporation". Lausanne. 2020-02-06
Illumina, Inc.. (2/6/20). "Press Release: Dr. Scott Gottlieb, Former US FDA Commissioner, Joins Illumina’s Board of Directors". San Diego, CA. 2020-02-06
Aimmune Therapeutics, Inc.. (2/5/20). "Press Release: Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science". Brisbane, CA. 2020-02-05
Aimmune Therapeutics, Inc.. (2/5/20). "Press Release: Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb7195 for the Development of Next-Generation Food Allergy Treatments". Brisbane, CA. 2020-02-05
MaaT Pharma. (2/5/20). "Press Release: MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics". Lyon. 2020-02-05
MorphoSys AG. (2/4/20). "Press Release: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.". Planegg. 2020-02-04
Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London. 2020-02-04
Catalent, Inc.. (2/3/20). "Press Release: Catalent to Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform". Somers, NJ & Gosselies. 2020-02-03
Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden. 2020-02-03
Stalicla S.A.. (2/3/20). "Press Release: Swiss Biotech Stalicla Announces Closure of USD 8M (CHF 7.7) for Second Tranche of Series A". Geneva. 2020-02-03
Catalent, Inc.. (2/3/20). "Press Release: Catalent, Inc. Announces Pricing of Public Offering of Common Stock". Somers, NJ. 2020-02-03
Valneva S.E.. (2/3/20). "Press Release: Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed". Saint-Herblain. 2020-02-03
Aimmune Therapeutics, Inc.. (1/31/20). "Press Release: FDA Approves Aimmune’s Palforzia as First Treatment for Peanut Allergy". Brisbane, CA. 2020-01-31
CureVac AG. (1/31/20). "Press Release: CureVac and CEPI Extend Their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019". Tübingen & Boston, MA & Oslo. 2020-01-31
Bayer AG. (1/31/20). "Press Release: Bayer Welcomes U.S. Environmental Protection Agency’s Reaffirmation that Glyphosate Is Safe to Use, Not Carcinogenic". Whippany, NJ. 2020-01-31
Vizgen. (1/30/20). "Press Release: Vizgen Launches with $14M Series A Financing Led by ARCH Venture Partners and Northpond Ventures". Cambridge, MA. 2020-01-30
Mammoth Biosciences, Inc.. (1/30/20). "Press Release: Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products for Therapeutics and Diagnostics". South San Francisco, CA. 2020-01-30
Quench Bio. (1/27/20). "Press Release: Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases". Cambridge, MA. 2020-01-27
Ipsen S.A.. (1/24/20). "Press Release: Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria". Paris. 2020-01-24
Santhera Pharmaceuticals Holding AG. (1/24/20). "Press Release: Santhera Appoints New Chief Financial Officer". Pratteln. 2020-01-24
Galapagos N.V.. (1/23/20). "Press Release: Galapagos Appoints Michele Manto as Chief Commercial Officer". Mechelen. 2020-01-23
PureTech Health plc. (1/23/20). "Press Release: PureTech Receives $200 Million from Sale of a Minority Portion of Affiliate Shares". 2020-01-23
Polyphor Ltd.. (1/23/20). "Press Release: Polyphor Appoints Gökhan Batur as Chief Executive Officer". Allschwil. 2020-01-23
Blueprint Genetics Oy. (1/22/20). "Press Release: Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases". 2020-01-22
Horizon Therapeutics plc. (1/21/20). "Press Release: FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)". Dublin. 2020-01-21
Bio-Techne Corporation. (1/21/20). "Press Release: Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies". Miami, FL. 2020-01-21
Exscientia Ltd.. (1/21/20). "Press Release: Exscientia Appoints Dr. David Hallett as Chief Operating Officer as Company Positions for Further Growth". 2020-01-21
Clarivate Analytics plc. (1/17/20). "Press Release: Clarivate Analytics to Acquire Decision Resources Group, Creating a Leading Global Provider of Data-Driven Solutions to the Life Sciences Industry". London & Philadelphia, PA. 2020-01-17
ERS Genomics Ltd.. (1/17/20). "Press Release: ERS Genomics Provides Comment on EPO Technical Board of Appeal Decision Upholding Revocation of Broad Institute CRISPR Patent". Dublin. 2020-01-17
Charles River Laboratories International, Inc.. (1/16/20). "Press Release: Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment". Wilmington, MA & Edinburgh. 2020-01-16
Qiagen N.V.. (1/16/20). "Press Release: Qiagen Launches Oncology Molecular Profiling Services in Europe. Qiagen Clinical Insights (QCI) Fully Integrates N-of-One Product into Portfolio". Redwood City, CA & Hilden. 2020-01-16
BioNTech SE. (1/16/20). "Press Release: BioNTech to Acquire Neon to Strengthen Global Leadership Position in T Cell Therapies". Mainz & Cambridge, MA. 2020-01-16
Sophia Genetics S.A.. (1/15/20). "Press Release: IDT Partners with Sophia Genetics to Increase Access to Clinical-grade Technologies". Coralville, IA. 2020-01-15
Galapagos N.V.. (1/15/20). "Press Release: Fibrocor and Galapagos Sign Expanded Collaboration in Fibrosis". Mechelen & Toronto. 2020-01-15
DNA Script. (1/15/20). "Press Release: IARPA Funds Team Involving DNA Script, the Broad Institute, and Harvard University for DNA Data Storage Research and Development". South San Francisco, CA. 2020-01-15
Jeito Capital. (1/15/20). "Press Release: Rafaèle Tordjman Launches Jeito Capital, a New Private Equity Company Dedicated to Biotech-biopharmaceuticals, and Announces the Closing of Jeito I at €200 Million". Paris. 2020-01-15
Valneva S.E.. (1/14/20). "Press Release: US DoD Exercises Option on Ixiaro Supply Contract Bringing Total Value to $70 Million". Saint-Herblain. 2020-01-14
Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire. 2020-01-14
Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA. 2020-01-14
MorphoSys AG. (1/13/20). "Press Release: MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab". Planegg & Wilmington, DE. 2020-01-13
ERS Genomics Ltd.. (1/13/20). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to Support Internal Research and Development". Dublin. 2020-01-13
KCR S.A.. (1/13/20). "Press Release: KCR Announces New Chief Commercial Officer. Bryan Katz Joins KCR’s Growing Executive Team to Take Over as Head of Commercial Strategy and Global Partnerships". Boston, MA. 2020-01-13
Galapagos N.V.. (1/13/20). "Press Release: Galapagos Completes Recruitment of PINTA Trial in Idiopathic Pulmonary Fibrosis". Mechelen. 2020-01-13
Qiagen N.V.. (1/13/20). "Press Release: Qiagen Builds on Global Collaboration with Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer". Hilden & Germantown, MD. 2020-01-13
BioNTech SE. (1/13/20). "Press Release: BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion". Mainz. 2020-01-13
Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. 2020-01-13
Roche. (1/13/20). "Press Release: Roche and Illumina Partner to Broaden Patient Access to Genomic Testing". Basel. 2020-01-13
Cellectis S.A.. (1/12/20). "Press Release: Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement". San Carlos, CA & New York, NY. 2020-01-12
EQRx, Inc.. (1/12/20). "Press Release: EQRx Launches to Create Innovative Medicines at Dramatically Lower Prices for People, Healthcare Systems and Society". Cambridge, MA. 2020-01-12
Tyra Biosciences, Inc.. (1/10/20). "Press Release: Tyra Biosciences Raises $50m to Develop Therapies Targeting Acquired Resistance in Oncology". Carlsbad, CA. 2020-01-10
Qiagen N.V.. (1/10/20). "Press Release: Qiagen Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony. Milestone Instrument Placed with Cenata GmbH in Germany". Hilden & Germantown, MD. 2020-01-10
Eli Lilly and Company. (1/10/20). "Press Release: Lilly Announces Agreement to Acquire Dermira". Indianapolis, IN & Menlo Park, CA. 2020-01-10
Emergex Vaccines Holding Ltd.. (1/9/20). "Press Release: Emergex Raises more than US$11 Million in a Series A Round to Progress its Pipeline of Set-point Vaccines for Infectious Diseases". Abingdon. 2020-01-09
Omniome, Inc.. (1/9/20). "Press Release: Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform". San Diego, CA. 2020-01-09
Selexis S.A.. (1/9/20). "Press Release: Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer". Geneva. 2020-01-09
Element Biosciences, Inc.. (1/9/20). "Press Release: Element Biosciences Raises $80M in Series B Financing to Accelerate Development of a New DNA Sequencing Platform". San Diego, CA. 2020-01-09
Almirall S.A.. (1/9/20). "Press Release: Almirall Enters into an Option Agreement to Acquire Bioniz Therapeutics and to Establish a Broad Research Agreement to Further Expand Its Innovative Pipeline in Medical Dermatology". Barcelona. 2020-01-09
Grey Wolf Therapeutics Ltd.. (1/9/20). "Press Release: Grey Wolf Completes £2.5 Million Series A2 Financing for Development of Therapies Targeting ERAP2". Oxford. 2020-01-09
Nurix Therapeutics, Inc.. (1/9/20). "Press Release: Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies". San Francisco, CA. 2020-01-09
Evotec SE. (1/9/20). "Press Release: Bayer and Evotec Form New Strategic Alliance Focusing on Polycystic Ovary Syndrome". Hamburg & Berlin. 2020-01-09
Almirall S.A.. (1/9/20). "Press Release: Almirall Signs a Strategic Agreement with 23andMe to License Rights of a Bispecific Monoclonal Antibody that Blocks All Three Isoforms of IL-36 Cytokine". Barcelona & Sunnyvale, CA. 2020-01-09
Valneva S.E.. (1/9/20). "Press Release: Valneva Expands its Commercial Operations with the Opening of its French Commercial Office". Saint-Herblain. 2020-01-09
GlaxoSmithKline plc. (1/8/20). "Press Release: Deborah Waterhouse, CEO of ViiV Healthcare, to Join GSK Corporate Executive Team (CET)". London. 2020-01-08
NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. 2020-01-08
BC Platforms. (1/8/20). "Press Release: BC Platforms Partners with Dante Labs to Build Europe's Largest Next Generation Sequencing Laboratory for Private and Public Customers". Zürich & Boston, MA. 2020-01-08
Eyevensys S.A.S.. (1/8/20). "Press Release: Eyevensys Closes $30M Series B Financing". Paris & Fort Worth, TX. 2020-01-08
ERS Genomics Ltd.. (1/7/20). "Press Release: ERS Genomics Announces Agreement with New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents". Dublin & Ipswich, MA. 2020-01-07
Bayer AG. (1/7/20). "Press Release: Bayer Exercises Right to Enter into Follow-on Research and Collaboration Option Agreement with Atomwise. Companies to Continue Crop Protection Development Programs". Monheim & San Francisco, CA. 2020-01-07
Evotec SE. (1/7/20). "Press Release: Evotec and Bristol-Myers Squibb Expand iPSC Collaboration". Hamburg. 2020-01-07
VectivBio AG. (1/7/20). "Press Release: VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases". Basel. 2020-01-07
Galecto Biotech AB. (1/7/20). "Press Release: Galecto and PharmAkea Merge to Create Strong Clinical-stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer". San Diego, CA & Copenhagen. 2020-01-07
Novome Biotechnologies, Inc.. (1/7/20). "Press Release: Novome Biotechnologies Raises $33 Million Series A Financing and Appoints Blake Wise as Chief Executive Officer". South San Francisco, CA. 2020-01-07
Novo Holdings A/S. (1/6/20). "Press Release: Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update". Copenhagen. 2020-01-06
MorphoSys AG. (12/30/19). "Press Release: MorphoSys Announces Submission of Biologics License Application for Tafasitamab in r/r DLBCL to the FDA". Planegg. 2019-12-30
Elpiscience Biopharma. (12/28/19). "Press Release: Elpiscience Completes Series B Financing of USD $100 Million". Shanghai. 2019-12-28
Astellas Pharma Inc.. (12/27/19). "Pressemitteilung: Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.". Tokyo & South San Francisco, CA. 2019-12-27
Codexis, Inc.. (12/23/19). "Press Release: Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing". Redwood City, CA. 2019-12-23
Savara Inc.. (12/20/19). "Press Release: Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million". Austin, TX. 2019-12-20
Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Resubmits New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. 2019-12-20
Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Announces $20 Million Registered Direct Offering". Dublin & King of Prussia, PA. 2019-12-20
Forma Therapeutics, Inc.. (12/19/19). "Press Release: Forma Therapeutics Announces Closing of $100 Million Series D Financing". Watertown, MA. 2019-12-19
Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. 2019-12-19
Merck KGaA. (12/19/19). "Press Release: Merck Licenses Foundational CRISPR Integration Technology to Promega". Darmstadt. 2019-12-19
1 2 3 ... 119 120 121  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75

» top